DI CARLO, EMMA
 Distribuzione geografica
Continente #
NA - Nord America 6.908
AS - Asia 4.703
EU - Europa 4.478
SA - Sud America 627
Continente sconosciuto - Info sul continente non disponibili 564
AF - Africa 74
OC - Oceania 7
Totale 17.361
Nazione #
US - Stati Uniti d'America 6.777
SG - Singapore 1.777
CN - Cina 1.424
UA - Ucraina 777
IE - Irlanda 631
TR - Turchia 570
IT - Italia 559
GB - Regno Unito 555
RU - Federazione Russa 518
BR - Brasile 508
SE - Svezia 457
FR - Francia 401
VN - Vietnam 390
DE - Germania 270
IN - India 193
FI - Finlandia 163
BD - Bangladesh 86
HK - Hong Kong 65
CA - Canada 48
AR - Argentina 44
MX - Messico 44
PL - Polonia 32
NL - Olanda 27
EC - Ecuador 26
IQ - Iraq 26
ES - Italia 23
KR - Corea 23
ZA - Sudafrica 23
JP - Giappone 22
PK - Pakistan 21
BE - Belgio 20
CL - Cile 13
UZ - Uzbekistan 13
AT - Austria 12
ID - Indonesia 11
IL - Israele 11
KE - Kenya 11
EG - Egitto 10
SA - Arabia Saudita 10
CR - Costa Rica 9
MA - Marocco 9
PY - Paraguay 9
VE - Venezuela 9
CO - Colombia 8
AE - Emirati Arabi Uniti 7
JO - Giordania 7
AU - Australia 6
CZ - Repubblica Ceca 6
JM - Giamaica 6
LT - Lituania 6
NP - Nepal 6
PH - Filippine 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
ET - Etiopia 5
HU - Ungheria 5
KZ - Kazakistan 5
RO - Romania 5
AZ - Azerbaigian 4
DZ - Algeria 4
EU - Europa 4
PE - Perù 4
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
GR - Grecia 3
GT - Guatemala 3
IR - Iran 3
TH - Thailandia 3
UY - Uruguay 3
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CH - Svizzera 2
HN - Honduras 2
KW - Kuwait 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
BM - Bermuda 1
BO - Bolivia 1
BS - Bahamas 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
GY - Guiana 1
KG - Kirghizistan 1
KY - Cayman, isole 1
LB - Libano 1
MM - Myanmar 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 16.795
Città #
Singapore 1.249
Jacksonville 841
San Jose 830
Chandler 704
Dublin 627
Southend 387
Dearborn 382
Council Bluffs 335
Ashburn 324
Beijing 314
Princeton 310
Dallas 291
Izmir 264
Nanjing 251
Wilmington 174
Los Angeles 146
Cambridge 140
The Dalles 129
Tongling 118
Ho Chi Minh City 117
New York 113
Santa Clara 102
Altamura 98
Buffalo 78
Hanoi 78
Nanchang 78
Ann Arbor 73
Chieti 70
Boardman 69
Hong Kong 64
Moscow 62
Woodbridge 54
Shenyang 47
Pescara 45
Hefei 43
São Paulo 43
Hebei 39
Romola 37
Chennai 36
Kunming 36
Grevenbroich 34
Dong Ket 32
Jiaxing 31
Orem 30
Redondo Beach 30
Columbus 29
Houston 29
Tianjin 28
Warsaw 27
Denver 24
Guangzhou 21
Hangzhou 21
Seoul 21
Brooklyn 20
Milan 20
Tokyo 20
Jinan 19
Norwalk 19
Da Nang 18
Phoenix 18
Atlanta 17
Boston 17
Changsha 17
Düsseldorf 17
Helsinki 17
Johannesburg 17
Chicago 16
Mexico City 16
Orange 16
Amsterdam 15
Brussels 15
Manchester 15
San Francisco 15
Frankfurt am Main 14
Toronto 14
Poplar 13
Falls Church 12
Lanciano 12
Tashkent 12
Haiphong 11
Munich 11
Nuremberg 11
Rio de Janeiro 11
Seattle 11
St Louis 11
Washington 11
Auburn Hills 10
Augusta 10
Curitiba 10
London 10
Nairobi 10
Rome 10
Baghdad 9
Belo Horizonte 9
Leawood 9
Memphis 9
Ninh Bình 9
Shanghai 9
Stockholm 9
Caxias do Sul 8
Totale 10.184
Nome #
Interleukin-30/IL-27p28 shapes prostate cancer stem-like cell behavior and is critical for tumor onset and metastasization 158
The prostate-associated lymphoid tissue (PALT) is linked to the expression of homing chemokines CXCL13 and CCL21. 157
CD25+ Regulatory T Cell Depletion Augments Immunotherapy of Micrometastases by an IL-21-Secreting Cellular Vaccine. 157
In vivo studies of cytokines and growth factors involved in inflammation by using engineered tumor cells as biological minipumps. 154
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. 154
Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice. 153
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 153
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. 150
Upregulation of TMEM16A protein in bronchial epithelial cells by bacterial pyocyanin 150
Interleukin 6 gene transfected mouse mammary adenocarcinoma cells displaying an "in vitro" increased cell growth show an "in vivo" low tumor progression and a high metastatic potential. 148
EDAP a member of TNF ligand superfamily is able to induce macrophage-granulocyte cross-talk. 147
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. 147
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 142
IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions. 142
Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival 140
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph 139
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 136
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 136
Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients. 135
Absence of IL-12Rβ2 in CD33(+)CD38(+) pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice. 135
SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression 135
Endomyocardial infiltration by B and NK cells foreshadows the recurrence of cardiac allograft rejection 134
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 133
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype and predicts clinical outcome 132
Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway 130
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. 129
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver 128
Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo. 128
Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model. 127
Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival 127
Interaction Between Endothelial Cells and the Secreted Cytokine Drives the Fate of An IL4- or An IL 5-Transduced Tumour 126
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model 126
Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer 126
Quilty effect has the features of lymphoid neogenesis and shares CXCL13-CXCR5 pathway with recurrent acute cardiac rejections 126
Interleukin-30 Promotes Breast Cancer Growth and Progression 124
Targeting tumor-related immunosuppression for cancer immunotherapy. 123
Proinflammatory cytokines IL1 and IL6 are autocrine and/or paracrine growth factors for normal and neoplastic epithelial cells from human uterine cervix. 123
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. 122
SPARC/Osteonectin production by tumor infiltrating macrophages promotes breast cancer metastatization. 122
Down regulation of major histocompatibility complex class I expression in mammary carcinoma of Her-2/neu trangenic mice 120
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. 120
Constitutive expression of IL-12RB2 on human multiple myeloma cells delineates a novel therapeutic target. 120
Neutrophils in anti-cancer immunological strategies: old players in new games 120
Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice. 120
Local release of IL-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti- inflammatory activity resulting in a delayed tumour rejection. 119
Interleukin 12-mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice 119
CX3CL1/Fractalkine expression by antigen presenting cells and endothelial cells leads to NK cell recruitment in human cardiac allograft rejection. 119
Targeting of IL-12 to human non small cell lung cancer counters tumor growth in vivo 119
Immunoliposome-based targeted delivery of the CRISPR/Cas9gRNA-IL30 complex inhibits prostate cancer and prolongs survival 118
Clinical impact of the lung tissue transcriptome in a teenager with multifocal invasive mucinous adenocarcinoma-a case report 118
Immune Events Associated with the Cure Established Tumors and Spontaneous Metastases by Local and Systemic Interlukin 12 117
The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance. 117
IL-12 mediated prevention of spontaneous tumors in C-neu transgenic inbred BALB/c and FVB mice. 117
NCR + ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures 117
The Immune Response Elicited by Mammary Adenocarcinoma Cells Transduced with Interferon-y and Cytosine Deaminase Genes Cures Lung Metastases by Parental Cells 116
Direct inhibition of human acute myeloid leukemia cell growth by IL-12. 116
Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy. 116
Immunopathological alterations of the prostate-associated lymphoid tissue (PALT) by androgen ablation in patients with prostate cancer 115
Interleukin-30 expression in prostate cancer and its draining lymph nodes correlates with advanced grade and stage 115
L'angiogenesi e le alterazioni vascolari giocano un ruolo cruciale nel promuovere o inibire la crescita tumorale di un adenocarcinoma mammario murino ingegnerizzato con i geni di IL5 o di IL4. 115
p185neu protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma 114
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 114
Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells. 114
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 114
Interferon (IFN)-beta Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-alpha. Differential Effects on Tumorigenicity and Host Response 113
OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response. 113
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 113
The role of B lymphocytes and NK cells in cardiac allograft rejection. 113
Dendritic cell recognition by ILC3 via DNAM-1 triggers pro-inflammatory reciprocal cell activations 113
The prostate-associated lymphoid tissue (PALT) is driven by CXCL13 and CCL21 expression. 112
SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis 112
Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice. 110
The Quilty Effect: an actor in search of a part 110
The prostate-associated lymphoid tissue (PALT) is heavily compromised in prostate cancer but differently altered depending on androgen ablation. 110
Oxidative Stress and Age-Related Tumors 109
Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice 108
Signaling through 3',5'-Cyclic Adenosine Monophosphate and Phosphoinositide-3 Kinase Induces Sodium/Iodide Symporter Expression in Breast Cancer. 108
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 108
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. 108
Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential. 107
Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination. 107
Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice. 106
Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis. 105
Immunological prevention of a multigene cancer syndrome. 105
Interleukin-27 Acts as Multifunctional Anti-Tumor Agent in Multiple Myeloma. 105
Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells. 105
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes. 104
The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement. 104
EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells 104
The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies. 103
Colorectal cancer development is affected by the ECM molecule EMILIN-2 hinging on macrophage polarization via the TLR-4/MyD88 pathway 102
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas. 102
The enigmatic role of interleukin-12 in the pathogenesis of Sjögren's syndrome: comment on the article by Vosters et al. 102
Network of immunoregolatory cell subsets and mediators involved in human cardiac allograft rejection. 102
Gene transfer of a modified human IL-15 cDNA in lung cancer cells: analyses of biological effects. 102
The antitumor potential of Interleukin-27 in prostate cancer 101
Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. 100
The lack of IL-7 and BAFF/BLyS gene expression in prostate cancer as a mechanism of tumor escape from immuno-surveillance. 100
Mechanisms of the Antitumor Activity of Human Vγ9Vδ2 T Cells in Combination With Zoledronic Acid in a Preclinical Model of Neuroblastoma. 99
Decoding the Role of Interleukin-30 in the Crosstalk Between Cancer and Myeloid Cells 99
Totale 12.107
Categoria #
all - tutte 69.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.381


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022556 0 9 8 91 52 16 11 52 40 25 71 181
2022/20232.099 175 212 114 254 222 442 114 142 290 51 54 29
2023/2024791 77 34 48 20 36 246 231 15 1 12 8 63
2024/20252.435 157 318 316 95 44 62 38 152 296 134 300 523
2025/20265.345 459 305 553 640 397 318 865 442 521 450 276 119
2026/2027356 112 244 0 0 0 0 0 0 0 0 0 0
Totale 17.361